Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BLISS GVS PHARMA vs MERCURY LAB. - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BLISS GVS PHARMA MERCURY LAB. BLISS GVS PHARMA/
MERCURY LAB.
 
P/E (TTM) x 13.1 24.3 54.0% View Chart
P/BV x 1.3 2.2 61.6% View Chart
Dividend Yield % 0.4 0.4 105.5%  

Financials

 BLISS GVS PHARMA   MERCURY LAB.
EQUITY SHARE DATA
    BLISS GVS PHARMA
Mar-23
MERCURY LAB.
Mar-23
BLISS GVS PHARMA/
MERCURY LAB.
5-Yr Chart
Click to enlarge
High Rs911,000 9.1%   
Low Rs67390 17.3%   
Sales per share (Unadj.) Rs72.2627.8 11.5%  
Earnings per share (Unadj.) Rs7.446.5 15.8%  
Cash flow per share (Unadj.) Rs9.267.2 13.6%  
Dividends per share (Unadj.) Rs0.503.50 14.3%  
Avg Dividend yield %0.60.5 125.2%  
Book value per share (Unadj.) Rs84.0380.2 22.1%  
Shares outstanding (eoy) m104.151.20 8,679.2%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.11.1 99.3%   
Avg P/E ratio x10.814.9 72.0%  
P/CF ratio (eoy) x8.710.3 83.7%  
Price / Book Value ratio x0.91.8 51.7%  
Dividend payout %6.87.5 90.1%   
Avg Mkt Cap Rs m8,262834 990.6%   
No. of employees `000NANA-   
Total wages/salary Rs m862139 619.6%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m7,516753 997.7%  
Other income Rs m17817 1,034.7%   
Total revenues Rs m7,694771 998.5%   
Gross profit Rs m1,17386 1,361.2%  
Depreciation Rs m18725 752.0%   
Interest Rs m1044 2,863.0%   
Profit before tax Rs m1,06175 1,415.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m29319 1,532.8%   
Profit after tax Rs m76756 1,375.4%  
Gross profit margin %15.611.4 136.4%  
Effective tax rate %27.725.5 108.3%   
Net profit margin %10.27.4 137.9%  
BALANCE SHEET DATA
Current assets Rs m6,974417 1,672.0%   
Current liabilities Rs m1,933164 1,176.4%   
Net working cap to sales %67.133.6 199.9%  
Current ratio x3.62.5 142.1%  
Inventory Days Days397 541.1%  
Debtors Days Days1,8711,035 180.7%  
Net fixed assets Rs m4,562259 1,763.5%   
Share capital Rs m10412 867.9%   
"Free" reserves Rs m8,646444 1,946.0%   
Net worth Rs m8,750456 1,917.6%   
Long term debt Rs m40724 1,680.7%   
Total assets Rs m11,535676 1,707.0%  
Interest coverage x11.221.7 51.8%   
Debt to equity ratio x00.1 87.6%  
Sales to assets ratio x0.71.1 58.4%   
Return on assets %7.68.8 85.9%  
Return on equity %8.812.2 71.7%  
Return on capital %12.716.3 77.8%  
Exports to sales %025.3 0.0%   
Imports to sales %00.4 0.0%   
Exports (fob) Rs mNA191 0.0%   
Imports (cif) Rs mNA3 0.0%   
Fx inflow Rs m5,618191 2,945.1%   
Fx outflow Rs m1,2258 15,500.6%   
Net fx Rs m4,394183 2,402.7%   
CASH FLOW
From Operations Rs m34325 1,399.4%  
From Investments Rs m-78-11 733.3%  
From Financial Activity Rs m-249-10 2,461.9%  
Net Cashflow Rs m304 788.5%  

Share Holding

Indian Promoters % 35.0 73.7 47.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 22.0 0.0 -  
FIIs % 15.4 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 65.0 26.3 246.9%  
Shareholders   40,758 1,161 3,510.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BLISS GVS PHARMA With:   DIVIS LABORATORIES    SUN PHARMA    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on BLISS GVS PHARMA vs MERCURY LAB.

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

BLISS GVS PHARMA vs MERCURY LAB. Share Price Performance

Period BLISS GVS PHARMA MERCURY LAB. S&P BSE HEALTHCARE
1-Day -1.31% -4.12% 1.18%
1-Month -9.12% -3.92% -0.75%
1-Year 58.26% 56.06% 61.82%
3-Year CAGR 3.89% 9.86% 18.16%
5-Year CAGR -8.75% 20.84% 19.79%

* Compound Annual Growth Rate

Here are more details on the BLISS GVS PHARMA share price and the MERCURY LAB. share price.

Moving on to shareholding structures...

The promoters of BLISS GVS PHARMA hold a 35.0% stake in the company. In case of MERCURY LAB. the stake stands at 73.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of BLISS GVS PHARMA and the shareholding pattern of MERCURY LAB..

Finally, a word on dividends...

In the most recent financial year, BLISS GVS PHARMA paid a dividend of Rs 0.5 per share. This amounted to a Dividend Payout ratio of 6.8%.

MERCURY LAB. paid Rs 3.5, and its dividend payout ratio stood at 7.5%.

You may visit here to review the dividend history of BLISS GVS PHARMA, and the dividend history of MERCURY LAB..

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.